由于过度使用长效β激动剂而引起的乳酸
Saho Katsumata1, Hirohisa Fujikawa2,1, Takashi Nakamura1
1Department of Internal Medicine, Suwa Central Hospital, Nagano, JPN.
Cureus
|July 29, 2024
概括
长效β激动剂 (LABAs) 的过度使用可能导致乳酸性酸症,这是一种严重的疾病,在重症监护中经常被忽视. 这一案例凸显了提高对药物诱导的代谢异常的临床意识的必要性.
科学领域:
- 关键护理医学 关键护理医学
- 药理学 药理学是指药理学的学科.
- 肺部病理学 肺部病理学
背景情况:
- 乳酸性酸症是一种关键护理并发症,与不良结果有关.
- 乙型乳酸性酸症包括代谢异常,药物诱导的原因经常被忽视.
- 长效β激动剂 (LABAs) 是常见的喘和COPD药物.
研究的目的:
- 报告一种由于过度使用LABA引起的罕见乳酸性化病例.
- 强调在代谢酸中考虑药物诱导原因的重要性.
- 提高临床对LABA相关的乳酸酸性化症的认识.
主要方法:
- 一个患有喘-COPD重叠恶化症的患者的病例报告.
- 诊断评估,包括乳酸水平评估和病史.
- 治疗重点是适当的吸入疗法.
主要成果:
- 患者呈现了严重的乳酸酸和源不明的代谢酸.
- 药物诱导的乳酸性酸症的诊断在过度吸入LABA史后得到证实.
- 乳酸盐水平和呼吸系统状况在调整后的吸入治疗中得到改善.
结论:
- 过度使用LABA可以导致乳酸化,一种B型代谢异常.
- 提高临床医生的意识至关重要,以防止误诊并确保适当的患者管理.
- 这一案例凸显了LABAs与短效β激动剂一样有可能诱导乳酸性酸性疾病的潜力.
更多相关视频
06:45Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
2.7K
09:31Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
Published on: November 5, 2016
7.2K
相关概念视频
Antiasthma Drugs: β2-Adrenoceptor Agonists
244
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
244
Muscle Recovery and Fatigue
2.0K
Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective...
2.0K
Glucagon-like Receptor Agonists
312
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
312
Desensitization and Tachyphylaxis
1.6K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.6K
Acute Respiratory Failure-III
167
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
167
Adrenergic Antagonists: ɑ and β-Receptor Blockers
429
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
429
